| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |